PD18-01 ASA CLASSIFICATION AND CHARLSON SCORE AS PREDICTORS OF 90-DAY MORTALITY AFTER RADICAL CYSTECTOMY

CONCLUSIONS: No reliable effective preventative therapy has been identified for RIP. In our relatively sizable single center experience, KTZ appears to be a reasonably effective, safe, and inexpensive treatment to prevent RIP while preserving sexual function. We now recommend our tapered dose regimen listed above. After six months we recommend stopping the medication as we have found a majority of patients will not need to resume nightly KTZ.